These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10969818)

  • 1. p53 promotes selection for Fas-mediated apoptotic resistance.
    Maecker HL; Koumenis C; Giaccia AJ
    Cancer Res; 2000 Aug; 60(16):4638-44. PubMed ID: 10969818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
    Tamura T; Aoyama N; Saya H; Haga H; Futami S; Miyamoto M; Koh T; Ariyasu T; Tachi M; Kasuga M
    Oncogene; 1995 Nov; 11(10):1939-46. PubMed ID: 7478511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
    Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis.
    Yakes FM; Wamil BD; Sun F; Yan HP; Carter CE; Hellerqvist CG
    Cancer Res; 2000 Oct; 60(20):5740-6. PubMed ID: 11059768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
    Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
    Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC; López-Rivas A
    Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
    Burns TF; Bernhard EJ; El-Deiry WS
    Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system.
    Caricchio R; Kovalenko D; Kaufmann WK; Cohen PL
    Clin Immunol; 1999 Oct; 93(1):65-74. PubMed ID: 10497012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta.
    Fuchs EJ; McKenna KA; Bedi A
    Cancer Res; 1997 Jul; 57(13):2550-4. PubMed ID: 9205051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas (CD95, APO-1) antigen expression and function in murine mast cells.
    Hartmann K; Wagelie-Steffen AL; von Stebut E; Metcalfe DD
    J Immunol; 1997 Oct; 159(8):4006-14. PubMed ID: 9378990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.
    Lafleur EA; Jia SF; Worth LL; Zhou Z; Owen-Schaub LB; Kleinerman ES
    Cancer Res; 2001 May; 61(10):4066-71. PubMed ID: 11358827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation in JNK activation and p53-dependent Fas expression induced by apoptotic stimuli.
    Chen YR; Tan TH
    Biochem Biophys Res Commun; 1999 Mar; 256(3):595-9. PubMed ID: 10080943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of apoptosis in normal ontogenesis and solid human neoplasms.
    Kaiser HE; Bodey B
    In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells.
    Unger C; Buchmann A; Bünemann CL; Kress S; Schwarz M
    Cell Death Differ; 1998 Jan; 5(1):87-95. PubMed ID: 10200449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
    Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
    Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.